Pasqal eyes $2B SPAC debut on NASDAQ
French quantum computing company Pasqal, backed by Nobel Prize–winning science, is preparing to go public in the United States via a SPAC merger that would value the business at around $2 billion. The planned listing on NASDAQ would make the firm one of Europe’s most highly valued pure-play quantum computing companies on public markets.
Nobel-winning science behind the company
Pasqal is built on research that contributed to a Nobel Prize in Physics, using neutral-atom architectures to build scalable quantum processors. The company positions its platform as a competitor to more established superconducting qubit and trapped-ion approaches, arguing that its technology can be more easily scaled to large numbers of qubits while maintaining stability.
From lab breakthrough to commercial rollout
The planned SPAC transaction is designed to give Pasqal the capital needed to move from research-heavy prototypes to full commercial deployment. Funds raised would be directed toward expanding R&D, building larger quantum data centers, and hiring specialists in quantum algorithms, error mitigation, and application engineering.
Riding the quantum investment wave
The deal underscores investor appetite for deeptech and quantum computing despite broader volatility in public markets and a cooling of the SPAC boom. A successful listing could provide a fresh benchmark for valuations in the sector and intensify competition with US and Asian rivals racing to achieve quantum advantage in areas such as optimization, materials science, and cryptography.
Implications for Europe’s tech ecosystem
By targeting a US listing, Pasqal highlights the ongoing tension between Europe’s strong scientific base and its relatively shallow late-stage capital markets. If the $2 billion SPAC debut proceeds as planned, it may encourage more European deeptech startups to tap US exchanges for scale, while increasing pressure on European policymakers and investors to deepen local capital pools for frontier technologies.